Index
550
Reactive oxygen species (ROS), 60
Ribonucleic acid (RNA), 37, 48, 99, 100, 122,
182, 510
S
Side effects, 27, 113
Simplex representation of molecular structure
(SiRMS), 470, 473, 476, 479
Solubility, 273, 462, 464, 465, 477, 495
Structural analysis, 25, 126
of pol-inhibitor interactions, 114–118
Structure, 13, 23, 26, 31, 35, 42, 64, 139, 171,
190, 279
vibrational, 15
Sugar complexes, 281
Supramolecular complexes, 449, 451, 455
T
Telomerase inhibitors, 198
Thermodynamics, 27, 35, 222
statistical, 514
Toxicogenomics, 542
V
Virtual screening, 124, 186, 434, 441, 446,
448, 454, 455, 474, 503, 508, 516,
517, 519, 521, 525, 527–530, 541
α-helical peptide, 241, 243, 250
Précédent

- 556/556